Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-08
2005-03-08
Powers, Flona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S389000, C514S391000, C514S392000, C514S397000, C548S311400
Reexamination Certificate
active
06864273
ABSTRACT:
The present invention concerns compounds of formula (I)a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein —Z1—Z2— is a bivalent radical; R1, R2and R3are each independently selected from hydrogen, C1-6alkyl, hydroxy, halo and the like; or when R1and R2are on adjacent carbon atoms, R1and R2taken together may form a bivalent radical of formula; Alk1and Alk2are optionally substituted C1-6alkanediyl; R6is hydrogen or phenylmethyl; R5is a radical of formulawherein n is 1 or 2; p1is 0, and p2is 1 or 2; or p1is 1 or 2, and p2is 0; X is oxygen, sulfur or ═NR9; Y is oxygen or sulfur; R7is hydrogen, C1-6alkyl, C3-6cycloalkyl, phenyl or phenylmethyl; R8is C1-6alkyl, C3-6cycloalkyl phenyl or phenylmethyl; R9is cyano, C1-6alkyl, C3-6cyclo-alkyl, C1-6alkyloxycarbonyl or aminocarbonyl; R10is hydrogen or C1-6alkyl; and Q is a bivalent radical. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impaired fundic relaxation.
REFERENCES:
patent: 3910930 (1975-10-01), Janssen et al.
patent: 3929801 (1975-12-01), Janssen et al.
patent: 4329348 (1982-05-01), Huebner
patent: 4470989 (1984-09-01), Henning et al.
patent: 4849335 (1989-07-01), Hofnung et al.
patent: 5137901 (1992-08-01), Junge et al.
patent: 5371094 (1994-12-01), Heine et al.
patent: 5492918 (1996-02-01), Wild et al.
patent: 5541199 (1996-07-01), Mewshaw
patent: 5696136 (1997-12-01), Heine et al.
patent: 6133277 (2000-10-01), Wigerinck et al.
patent: 6495547 (2002-12-01), Wigerinck et al.
patent: 20040019051 (2004-01-01), Van emelen et al.
patent: 28 52 945 (1980-06-01), None
patent: 0 048 218 (1981-09-01), None
patent: 0004358 (1982-01-01), None
patent: 0 068 261 (1983-01-01), None
patent: 0106749 (1988-12-01), None
patent: 2019837 (1979-11-01), None
patent: WO 9317017 (1993-09-01), None
patent: WO 9505383 (1995-02-01), None
patent: WO 9728157 (1997-08-01), None
patent: WO 9929687 (1999-06-01), None
patent: WO 0075137 (2000-12-01), None
patent: WO 0198306 (2001-12-01), None
Attorney Docket No. JAB-1488, entitled “Pyrrolidinyl, Piperidinyl or Homopiperidinyl Substituted (Benzodioxan, Benzofuran or Benzopyran) Derivatives” being filed concurrently herewith.
T. Arakawa, U. Hironori, F. Takashi, K. Higuchi, K. Kobayaski, T. Kuroki, New Aspects of Gastric Adaptive Relaxation. Reflex after Food Intake for More Food: Involvement of Capsaicin-sensitive Sensory Nerves and Nitric Oxide, 1997, J. Smooth Muscle Res. 33:81-88.
De Bruyn Marcel Frans Leopold
Van Emelen Kristof
Janssen Pharmaceutica N.V.
Powers Flona T.
LandOfFree
Aminoalkyl substituted (benzodioxan, benzofuran or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkyl substituted (benzodioxan, benzofuran or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkyl substituted (benzodioxan, benzofuran or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384195